Matrix Private Capital Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Matrix Private Capital Group’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-961	Closed	-$73K	–	187
2023 Q1	$73K	Sell	961 -1,930	-67%	-$149K	0.05%	148
2022 Q4	$227K	Buy	2,891 +698	+32%	+$53.6K	0.15%	119
2022 Q3	$156K	Hold	2,193	–	–	0.11%	129
2022 Q2	$164K	Buy	+2,193	New	+$166K	0.09%	168
2021 Q2	–	Sell	-3,197	Closed	-$252K	–	253
2021 Q1	$252K	Buy	3,197 +1,063	+50%	+$82.9K	0.15%	149
2020 Q4	$152K	Buy	+2,134	New	+$143K	0.11%	163

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

PWW

Pettyjohn Wood & White Lynchburg, Virginia $687M AUM 24.61% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Matrix Private Capital Group's PJP Position: Q2 2023 in Review

Matrix Private Capital Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2023, closing a stake of 961 shares — an estimated $73K sold.

Matrix Private Capital Group first reported a position in PJP in Q4 2020 and held it in 6 quarters. The position peaked at $252K in Q1 2021. 87 funds tracked by Wall St. Rank hold PJP as of Q2 2023.

Matrix Private Capital Group reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2023 after selling out during the quarter.
Matrix Private Capital Group sold 961 Invesco Pharmaceuticals ETF shares in Q2 2023, an estimated $73K.
Matrix Private Capital Group first reported a position in Invesco Pharmaceuticals ETF in Q4 2020 and held it in 6 quarters.
Matrix Private Capital Group's Invesco Pharmaceuticals ETF position peaked at $252K in Q1 2021.
87 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2023.

Based on Matrix Private Capital Group's 13F filing for Q2 2023, filed 14 Aug 2023.